Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line from 3P innovation
Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to...
As 2024 wraps up, we’re taking a moment to celebrate an incredible year – and it’s all thanks to your support!
As we welcome 2025, we're taking a moment to celebrate an incredible year – and it’s all thanks to your support!
In May, we secured a multi-million-pound partnership with Canada-based Dalton Pharma Services (a Seikagaku Group company) to deliver an advanced robotic fill-finish cell. This deal further strengthens our position as the UK's leading supplier of aseptic fill-finish technology.
We joined forces with Cellular Origins, a TTP plc company, to supercharge the industrialisation of CGT manufacturing. By integrating our cryovial filling platform, cryoFIL™, with their robotic system, Constellation™, we’re breaking new ground in fully automated CGT production. This collaboration brings us closer to making life-saving therapies more accessible.
We showcased our innovations at nine events this year, including Phacilitate, Interphex, Achema, and CPHI! Keep an eye on where we’ll be next year here: Events | 3P Innovation
Last but not least, one of our engineers, Gemma Pollock won the runner-up spot at the ISPE UK Emerging Leaders Awards! This event highlights the incredible work of rising stars in pharmaceutical engineering – and we couldn’t be prouder!
Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to...
As 2024 wraps up, we’re taking a moment to celebrate an incredible year – and it’s all thanks to your support! As we welcome 2025, we're taking a...
Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation